Gerinnungsstörungen im Kindesalter

• Literatur

• 1 Reverdiau-Moalic P, Delahousse B, Bardos P et al. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996; 88: 900-906
• 2 Andrew M, Payes B, Milner R et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72: 1651-1657
• 3 Andrew M, Payes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990; 12: 95-104
• 4 Attard C, van der Straaten T, Karlaftis V et al. Developmental hemostasis: age-specific differences in the levels of hemostatic proteins. J Thromb Haemost 2013; 11: 1850-1854
• 5 Witt I, Müller H, Künzer W. Evidence for the existence of fetal fibrinogen. Thromb Diath Haemorrh 1969; 22: 101-109
• 6 Cvirn G, Gallistl S, Muntean W. Effects of antithrombin and protein C on thrombin generation in newborn and adult plasma. Thromb Res 1999; 93: 183-190
• 7 Andrew M, Schmidt B, Mitchell L et al. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin. Thromb Haemost 1990; 63: 27-30
• 8 Summaria L. Comparison of human normal, full-term, fetal and adult plasminogen by physical and chemical analyses. Haemostasis 1989; 19: 266-273
• 9 Saxonhouse MA, Sola MC. Platelet function in term and preterm neonates. Clin Perinatol 2004; 31: 15-18
• 10 Levy-Shraga Y, Maayan-Metzger A, Lubetsky A et al. Platelet function of newborns as tested by the Cone and Plate(let) analyser correlates with gestational age. Acts Haematol 2006; 115: 152-156
• 11 Del Vecchio A, Latini G, Henry E et al. Template bleeding time of 240 neonates born at 24 to 41 weeks gestation. J Perinatol 2008; 28: 427-423
• 12 Rajasekhar D, Barnard MR, Bednarek F. Platelet hyporeactivity in very low birth weight neonates. Thromb Haemost 1997; 77: 1002-1007
• 13 Israels SJ, Odaibo FS, Robertson C et al. Deficient Thromboxane synthesis and response in platelets from premature infants. Pediatr Res 1997; 41: 218-223
• 14 Yoffe G, Buchanan GR. Intracranial hemorrhage in newborn and young infants with hemophilia. J Pediatr 1988; 113: 333-336
• 15 Abbondanzo SL, Gootenberg JE, Lofts R et al. Intracranial hemorrhage in congenital deficiency of FXIII. Am J Pediatr Hematol Oncol 1988; 10: 65-68
• 16 Struwe FE. Intracranial hemorrhage and occlusive hydrocephalus in hereditary bleeding disorders. Dev Med Child Neurol 1970; 22: 165
• 17 Kenet G, Chan AK, Soucie JM et al. Bleeding disorders in neonates. Haemophilia 2010; 16: 168-174
• 18 Bidlingmaier C, Grote V, Budde U et al. Prospective evaluation of a pediatric bleeding questionnaire and the ISTH bleeding assessment tool in children and parents in routine clinical practice. J Thromb Haemost 2012; 10: 1335-1341
• 19 Doymaz S, Zinger M, Sweberg T. Risk factors associated with intracranial hemorrhage in neonates with persistent pulmonary hypertension on ECMO. J Intensive care 2015;
• 20 Retter A, Barrett NA. The management of abnormal haemostasis in the ICU. Anesthesia 2015; 70: 121-127
• 21 Whittaker B, Christiaans SC, Altice JL et al. Early coagulopathy is an independent predictor of mortality in children after severe trauma. Shock 2013; 39: 421-426
• 22 Bulutco FS, Özbek U, Polat B et al. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?. Ped Anesthesia 2005; 15: 41-46
• 23 Monagle P, Barnes C, Ignjatovic V et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost 2006; 95: 362-372
• 24 Ehrenforth S, Junker R, Koch HG et al. Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood. Childhood Thrombophilia Study Group. Eur J Pediatr 1999; 158 (Suppl. 03) S97-104
• 25 Nowak-Göttl U, Fröhlich B, Thedieck S et al. Association of the protein Z ATG haplotype with symptomatic nonvascular stroke or thromboembolism in white children: a family-based cohort study. Blood 2009; 113: 2336-2341
• 26 Beheiri A, Langer C, Düring C et al. Role of elevated alpha2-macroglobulin revisited: results of a case-control study in children with symptomatic thromboembolism. J Thromb Haemost 2007; 5: 1179-1184
• 27 Kreuz W, Stoll M, Junker R et al. Familial elevated factor VIII in children with symptomatic venous thrombosis and post-thrombotic syndrome: results of a multicenter study. Arterioscler Thromb Vasc Biol 2006; 26: 1901-1906
• 28 Burghaus B, Langer C, Thedieck S et al. Elevated alpha1-antitrypsin is a risk factor for arterial ischemic stroke in childhood. Acta Haematol 2006; 115: 186-191
• 29 Duering C, Kosch A, Langer C et al. Total tissue factor pathway inhibitor is an independent risk factor for symptomatic paediatric venous thromboembolism and stroke. Thromb Haemost 2004; 92: 707-712
• 30 Sainio S, Jarvenpaa AL, Renlund M et al. Throbocytopenia in term infants: a population-based study. Obstet Gynecol 2000; 95: 441-446
• 31 Holzhauer S, Zieger B. Diagnosis and management of neonatal thrombocytopenia. Sem Fet Neonal Med 2011; 16: 305-310
• 32 Peterson JA, Farland JG, Curtis BR et al. Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management. Br J Haematol 2013; 16: 3-14
• 33 Kamphuis MM, Paridaans NP, Porcelijn L et al. Incidence and consequences of neonatal alloimmune thrombocytopenia: a systematic review. Pediatrics 2014; 133: 715-721
• 34 Roberts JA, Murray NA. Neonatal thrombocytopenia. Cur Hematol Rep 2006; 5: 55-63
• 35 Ferrer-Marin F, Lju ZJ, Gutti R et al. Neonatal thronbocytopenia and megakaryocytopoiesis. Semin Hematol 2010; 47: 281-288
• 36 Castle V, Andrew M, Kelton J et al. Frequency and mechanism of neonatal thrombocytopenia. J Pediatr 1986; 108: 749-755
• 37 Sola-Visner M, Saxonhouse MA, Brown RE. Neonatal thrombocytopenia: what we do and dont’t know. Early Hum Dev 2008; 84: 499-506
• 38 Katz JA, Moake JL, McPherson PD et al. Relationship between human development and disappearance of unusually large von Willebrand factor multime rs from plasma. Blood 1989; 73: 1851-1858
• 39 Schlegel N, Bardet V, Kenet G et al. Diagnostic and therapeutic considerations on inherited platelet disorders in neonates and children. Klin Padiatr 2010; 222: 209-214
• 40 Halimeh S, Angelis G, Sander A et al. Multiplate whole blood impedance point of care aggregometry: preliminary reference values in healthy infants, children and adolescents. Klin Padiatr 2010; 222: 158-163
• 41 Sandrock-Lang K, Oldenburg J, Wiegering V et al. Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutations. Thromb Haemost 2015; 113: 782-791
• 42 Khair K, Liessner R. Bruising and bleeding in infants and children – a practical approach. Br J Haematol 2006; 133: 221-231
• 43 Brady KM, Easley RB, Tobias JD. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. Ped Anest 2006; 16: 1042-1046
• 44 Brettlet D, Levine P. Clinical manifestations and therapy of inherited coagulation factor deficiencies. In: Colman RW, Hirsh J, Marder VJ, et al., eds. Hemostasis and Thrombosis: Basic Principles and clinical practice. Philadelphia: J.B Lippincott; 1999: 169-183
• 45 Minford A, Behnisch W, Brons P et al. Subcutaneous protein C concentrate in the management of severe protein C deficiency – experience from 12 centres. Br J Haematol 2014; 164: 414-421
• 46 Kitchen S, Olson JD, Preston FE. Quality in Laboratory Hemostasis and Thrombosis. Hoboken: Wiley-Blackwell; 2009
• 47 Manner D, Kurnik K, Junker R et al. thromboermbolische Ereignisse im Kindes- und Jugendalter. Pädiatrie up2date 2010; 1: 1-16